Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesotherapy with Lidocaine and Proxicam for Chronic Migraine
NCT06118190Completed
- Sponsor
- Kanuni Sultan Süleyman Training and Research Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine and piroxicam in chronic migraine, sponsored by Kanuni Sultan Süleyman Training and Research Hospital. Primary endpoints: Visual Analog Scale at 12 weeks and The frequency of painful days per month at 12 weeks. Started Jan 2019; status: completed.
02
Drugs
lidocainepiroxicam
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT06118190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118190.